Garlic-derived compounds: Epigenetic modulators and their antitumor effects

Area of Science:

• Oncology
• Epigenetics
• Natural Products Chemistry

Background:

• Cancer remains a major global health threat with poor survival rates due to late diagnosis and treatment resistance.
• Natural products, particularly garlic-derived compounds, exhibit significant anticancer potential by targeting abnormal epigenetic modifications.
• Diallyl trisulfide (DATS), a major component of garlic, is recognized for its antioxidant and potential anticancer properties.

Purpose of the Study:

• To review the therapeutic advancements of garlic-derived compounds in cancer treatment.
• To elucidate the molecular mechanisms underlying the antitumor effects of these compounds, focusing on epigenetic pathways.
• To highlight the role of DATS as an epigenetic inhibitor in cancer therapy.

Main Methods:

• Literature review of studies on garlic-derived compounds and their effects on cancer.
• Analysis of research investigating the epigenetic mechanisms of action, including DNA demethylation and histone acetylation.
• Synthesis of findings on the therapeutic progress and molecular targets.

Main Results:

• Garlic-derived compounds, especially DATS, demonstrate anticancer effects through epigenetic modulation.
• DATS functions as an epigenetic inhibitor by enhancing CpG demethylation and promoting histone acetylation.
• These epigenetic modifications contribute to the observed antitumor activity of garlic compounds.

Conclusions:

• Garlic-derived compounds, particularly DATS, represent a promising avenue for cancer therapy through epigenetic targeting.
• Further research into these natural compounds could lead to novel, effective anticancer interventions.
• Understanding the epigenetic mechanisms provides a foundation for developing targeted cancer treatments.